AARTI DRUGS LTD.Long
Aarti Drugs Target 485-520
Market Expectation
At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year
If it grows profits by 15.4% per year, the stock should be priced at ₹488.23.
current share price is 11% Undervalued
Past Performance
Last year, profits declined by -21.6%
Profits over past 5 years grew by 26.3% per year
Forecast Range from 3 Analysts
To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year
To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year
Industry & Market Trend
Companies in the Pharmaceuticals industry grew profits by 4.4% last year
Companies in the India market grew profits by 30.8% last year
Company has delivered good profit growth of 21.37% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 26.13%
Good Risk to Reward Show
At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year
If it grows profits by 15.4% per year, the stock should be priced at ₹488.23.
current share price is 11% Undervalued
Past Performance
Last year, profits declined by -21.6%
Profits over past 5 years grew by 26.3% per year
Forecast Range from 3 Analysts
To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year
To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year
Industry & Market Trend
Companies in the Pharmaceuticals industry grew profits by 4.4% last year
Companies in the India market grew profits by 30.8% last year
Company has delivered good profit growth of 21.37% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 26.13%
Good Risk to Reward Show
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.